Yayın:
Safety of abt-450/r/ombitasvir plus dasabuvir with or without ribavirin in hcv genotype 1-infected patients: results from pearl ii, pearl iii, and pearl iv

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Gürel, Selim

Yazarlar

Lalezari, Jacob P.
Pruitt, Ronald
Luo, Yan
Aspinall, Richard
Gaeta, Giovanni
Olszok, Iwona
King, William L.
Hu, Yi-Ling
Enejosa, Jeffrey
Cohen, Daniel

Danışman

Dil

Türü

Yayıncı:

Wiley

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

Açıklama

Bu çalışma, 07-11, Kasım 2014 tarihlerinde Boston[ABD]’da düzenlenen 65. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases Kongresi‘nde bildiri olarak sunulmuştur.

Kaynak:

Anahtar Kelimeler:

Konusu

Gastroenterology & hepatology

Alıntı

Gürel, S. vd. (2014). "Safety of abt-450/r/ombitasvir plus dasabuvir with or without ribavirin in hcv genotype 1-infected patients: results from pearl ii, pearl iii, and pearl iv". Hepatology, 65. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, 60, Supplement: 1, Special Issue: SI, Meeting Abstract: 1961, 1151A-1151A.

Endorsement

Review

Supplemented By

Referenced By

7

Views

0

Downloads